Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Malaria in pregnancy (MiP) poses a dangerous health risk to both mothers and their fetuses, causing severe outcomes such as preterm delivery, intrauterine growth restriction, miscarriage, stillbirth, and neonatal and maternal death. Plasmodium falciparum infected erythrocytes sequester in placental intervillous spaces causing placental malaria (PM), eliciting inflammatory responses associated with severe sequelae. Current MiP prevention strategies have improved pregnancy outcomes, but serious morbidity and mortality persist. Vaccines to prevent MiP and PM are under development and are expected to improve pregnancy outcomes. To prepare for safety and efficacy trials of these vaccines, the incidence of adverse pregnancy outcomes including those caused by MiP should be documented at clinical sites. This review summarizes reported key adverse pregnancy outcomes attributable to MiP, providing important baseline context to define measurable safety and efficacy endpoints for malaria vaccine trials in pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, infants born to mothers with malaria have a higher risk of malaria infection and morbidity in early life [16–18].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maternal complications include severe anemia, increased susceptibility to other infections, and a higher mortality rate.”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The fetus and newborn are at risk of intrauterine growth retardation, low birth weight, premature birth, and increased neonatal mortality.”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“Consequently, this cascade of events can lead to impaired fetal growth and development, ultimately contributing to an unfavorable pregnancy outcome [10, 16, 181].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“Malaria in pregnancy has a complicated pathophysiology characterized by a complex interaction between the malaria parasite, the maternal immune system and the placenta [10, 16, 181].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stillbirths: rates, risk factors, and acceleration towards 2030
Lawn, J. E., Blencowe, H., Waiswa, P., Amouzou, A., Mathers, C., Hogan, D., Flenady, V., Frøen, J. F., Qureshi, Z. U., Calderwood, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00837-5 · Cited by 1,778
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
Hammond, A., Galizi, R., Kyrou, K., Simoni, A., Siniscalchi, C., Katsanos, D., Gribble, M., Baker, D., Marois, E., Russell, S., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3439 · Cited by 1,165
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
Self-citationCONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY
BREMAN, J. G., ALILIO, M. S., & MILLS, A. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.2_suppl.0700001 · Cited by 677
Maternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Self-citationWang, W., Sung, N., Gilman-Sachs, A., & Kwak-Kim, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02025 · Cited by 494
RTS,S/AS01 vaccine (Mosquirix™): an overview
Laurens, M. B. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1669415 · Cited by 491
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa
Guyatt, H. L., & Snow, R. W. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.760-769.2004 · Cited by 458
Pell, C., Meñaca, A., Were, F., Afrah, N. A., Chatio, S., Manda-Taylor, L., Hamel, M. J., Hodgson, A., Tagbor, H., Kalilani, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053747 · Cited by 399
Research works printed but not linked: 2
- DaviesL The GuardianGhana is first country to approve Oxford malaria vaccine2023
- EreziD The Guardian Nigeria News - Nigeria and World NewsNigeria approves Oxford malaria vaccine, to take immunisation action2023
Cited by
Malaria: past, present, and future
Li, Q., Liu, T., Lv, K., Liao, F., Wang, J., Tu, Y., & Chen, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02246-3 · Cited by 103
Current update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
Sallam, M., Khatib, A. O. A., Al-Mahzoum, K., Abdelaziz, D. H., & Sallam, M. (2025) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s513282 · Cited by 35
Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention
Wang, L., Idris, A. H., Kisalu, N. K., Crompton, P. D., & Seder, R. A. (2024) · Nature Immunology · doi:10.1038/s41590-024-01938-2 · Cited by 29
Wakai, T. N., Fiamitia, C., Kintung, I. F., Johngwe, M., Chinedu, S. N., & Afolabi, I. S. (2025) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2025.1686197 · Cited by 14
Metadata
- Authors
- Berhe, A. D., Doritchamou, J. Y. A., & Duffy, P. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Duffy, Patrick E.
- Venue
- Frontiers in Tropical Diseases
- Publisher
- Frontiers Media SA
- Published
- 2023-08-14
- Volume
- 4
- ISSN
- 2673-7515 (ISSN-L)
- OpenAlex
- W4385835641
- Cited by
- 30
- References
- 71
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 4 · 2023: 1
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Tropical Diseases (publishedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Keywords
- malaria in pregnancy, placental malaria, adverse pregnancy outcomes, Plasmodium falciparum, preterm birth, fetal growth restriction, miscarriage, stillbirth, neonatal mortality, maternal mortality, malaria vaccine, placental inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention. https://app.cochat.ai/papers/10.3389/fitd.2023.1229735
- The paper
- Berhe, A. D., Doritchamou, J. Y. A., & Duffy, P. E. (2023). Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention. Frontiers in Tropical Diseases. https://doi.org/10.3389/fitd.2023.1229735
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.